Discussion
Data are variable in relation to improvements in functional capacity and QOL. Some participants exhibited substantial
improvements in SMWT with others showing little or no improvement. There was no significant variance in QOL scoring pre- and post-intervention. It has been hypothesised that QOL tools commonly used in chronic HF are not reliable or valid means of measuring quality of life in this cohort group. More relevant assessment may be gained from assessing the individuals’ experience of chronic heart failure including treatment and care pathway (Calvert et al, 2005).